Royal Bank of Canada’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $768M | Buy |
|
|||||
|
2025
Q1 | $693M | Sell |
|
|||||
|
2024
Q4 | $802M | Buy |
|
|||||
|
2024
Q3 | $559M | Buy |
|
|||||
|
2024
Q2 | $437M | Sell |
|
|||||
|
2024
Q1 | $522M | Sell |
|
|||||
|
2023
Q4 | $862M | Sell |
|
|||||
|
2023
Q3 | $811M | Sell |
|
|||||
|
2023
Q2 | $860M | Buy |
|
|||||
|
2023
Q1 | $850M | Sell |
|
|||||
|
2022
Q4 | $973M | Buy |
|
|||||
|
2022
Q3 | $611M | Buy |
|
|||||
|
2022
Q2 | $567M | Buy |
|
|||||
|
2022
Q1 | $477M | Buy |
|
|||||
|
2021
Q4 | $522M | Buy |
|
|||||
|
2021
Q3 | $469M | Sell |
|
|||||
|
2021
Q2 | $471M | Sell |
|
|||||
|
2021
Q1 | $446M | Buy |
|
|||||
|
2020
Q4 | $397M | Buy |
|
|||||
|
2020
Q3 | $422M | Buy |
|
|||||
|
2020
Q2 | $460M | Sell |
|
|||||
|
2020
Q1 | $450M | Buy |
|
|||||
|
2019
Q4 | $359M | Buy |
|
|||||
|
2019
Q3 | $245M | Buy |
|
|||||
|
2019
Q2 | $222M | Buy |
|
|||||
|
2019
Q1 | $141M | Sell |
|
|||||
|
2018
Q4 | $137M | Sell |
|
|||||
|
2018
Q3 | $201M | Sell |
|
|||||
|
2018
Q2 | $185M | Sell |
|
|||||
|
2018
Q1 | $250M | Buy |
|
|||||
|
2017
Q4 | $236M | Buy |
|
|||||
|
2017
Q3 | $262M | Sell |
|
|||||
|
2017
Q2 | $277M | Buy |
|
|||||
|
2017
Q1 | $216M | Sell |
|
|||||
|
2016
Q4 | $283M | Sell |
|
|||||
|
2016
Q3 | $388M | Sell |
|
|||||
|
2016
Q2 | $462M | Buy |
|
|||||
|
2016
Q1 | $485M | Sell |
|
|||||
|
2015
Q4 | $552M | Buy |
|
|||||
|
2015
Q3 | $428M | Buy |
|
|||||
|
2015
Q2 | $508M | Buy |
|
|||||
|
2015
Q1 | $294M | Sell |
|
|||||
|
2014
Q4 | $301M | Buy |
|
|||||
|
2014
Q3 | $290M | Buy |
|
|||||
|
2014
Q2 | $221M | Buy |
|
|||||
|
2014
Q1 | $174M | Sell |
|
|||||
|
2013
Q4 | $307M | Buy |
|
|||||
|
2013
Q3 | $253M | Buy |
|
|||||
|
2013
Q2 | $197M | Buy |
|